Leyi Yu

机构：Tongji University, Ningxia University, Fifth Hospital of Shijiazhuang, Ningxia Medical University, The Fourth People's Hospital of Ningxia Hui Autonomous Region · ORCID：0009-0002-6614-6582

发表论文 13 篇 · 总被引 100 次 · h-index 6

代表论文

• Fibronectin-targeting and metalloproteinase-activatable smart imaging probe for fluorescence imaging and image-guided surgery of breast cancer (2023 · Journal of Nanobiotechnology · 被引 33)
• Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 22)
• Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives (2023 · Journal of Controlled Release · 被引 12)
• Study on the effects and mechanisms of Wenzhong Bushen Formula in improving ovarian reserve decline in mice based on network pharmacology (2024 · Journal of Ethnopharmacology · 被引 11)
• Metformin modulates the TXNIP-NLRP3-GSDMD pathway to improve diabetic bladder dysfunction (2024 · Scientific Reports · 被引 6)
• Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future (2022 · Molecular Imaging and Biology · 被引 6)